We provide you with 20 years of free, institutional-grade data for AXGN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AXGN. Explore the full financial landscape of AXGN stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$1,657,131
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Weiler Kathy Johnson | Derivatives Exercise | 14,150 | 2026-06-23 | ||
| Wendell Amy McBride | Derivatives Exercise | 14,150 | 2026-06-23 | ||
| THOMAS PAUL | Derivatives Exercise | 18,867 | 2026-06-23 | ||
| TYNDALL JOSEPH A. | Derivatives Exercise | 14,150 | 2026-06-23 | ||
| JOHNSON JOHN | Derivatives Exercise | 14,150 | 2026-06-23 | ||
| Burke William P. Mr. | Derivatives Exercise | 14,150 | 2026-06-23 | ||
| Levine Alan M | Derivatives Exercise | 14,150 | 2026-06-23 | ||
| Wendell Amy McBride | Sale | -1,647 | $42.6 | $70,162 | 2026-05-12 |
| Wendell Amy McBride | Derivatives Exercise | 1,647 | 2026-05-12 | ||
| JOHNSON JOHN | Sale | -11,050 | $43.26 | $477,968 | 2026-05-08 |
| JOHNSON JOHN | Derivatives Exercise | 11,050 | 2026-05-08 | ||
| Weiler Kathy Johnson | Sale | -16,344 | $44.09 | $720,623 | 2026-05-08 |
| Weiler Kathy Johnson | Derivatives Exercise | 16,344 | 2026-05-08 | ||
| Kemp Jens | Sale | -4,000 | $43.44 | $173,761 | 2026-05-08 |
| Hartley Lindsey Marie | Sale | -1,051 | $43.67 | $45,897 | 2026-05-08 |
| Hartley Lindsey Marie | Derivatives Exercise | 5,463 | 2026-05-08 | ||
| Quackenbush Doris | Sale | -3,878 | $43.51 | $168,720 | 2026-05-08 |
| Quackenbush Doris | Initial | 2026-05-08 | |||
| Hartley Lindsey Marie | Sale | -3,542 | $32.84 | $116,319 | 2026-03-18 |
| Hartley Lindsey Marie | Derivatives Exercise | 9,000 | 2026-03-18 | ||
| DeVinney Erick Wayne | Sale | -8,091 | $32.84 | $265,708 | 2026-03-18 |
| DeVinney Erick Wayne | Derivatives Exercise | 17,938 | 2026-03-18 | ||
| Kemp Jens | Sale | -18,366 | $31.9 | $585,875 | 2026-03-02 |
| Kemp Jens | Grant, award...etc | 50,670 | 2026-03-02 | ||
| DeVinney Erick Wayne | Sale | -21,978 | $31.9 | $701,098 | 2026-03-02 |
| DeVinney Erick Wayne | Grant, award...etc | 33,780 | 2026-03-02 | ||
| Began Marc A | Derivatives Exercise | 11,250 | 2026-03-02 | ||
| Began Marc A | Sale | -13,180 | $31.9 | $420,442 | 2026-03-02 |
| Began Marc A | Grant, award...etc | 33,780 | 2026-03-02 | ||
| Hartley Lindsey Marie | Sale | -6,630 | $31.9 | $211,497 | 2026-02-27 |
| Hartley Lindsey Marie | Grant, award...etc | 17,453 | 2026-02-27 | ||
| Hartley Lindsey Marie | Sale | -6,704 | $35.38 | $237,188 | 2026-02-24 |
| Hartley Lindsey Marie | Grant, award...etc | 17,500 | 2026-02-24 | ||
| Hartley Lindsey Marie | Sale | -14,812 | $29.86 | $442,294 | 2025-12-17 |
| Hartley Lindsey Marie | Derivatives Exercise | 14,812 | 2025-12-17 | ||
| Wendell Amy McBride | Sale | -43,684 | $29.31 | $1,280,465 | 2025-12-17 |
| Wendell Amy McBride | Derivatives Exercise | 43,684 | 2025-12-17 | ||
| Weiler Kathy Johnson | Sale | -46,653 | $29.55 | $1,378,456 | 2025-12-17 |
| Weiler Kathy Johnson | Derivatives Exercise | 40,073 | 2025-12-17 | ||
| DALE MICHAEL D | Sale | -25,000 | $30 | $750,000 | 2025-12-12 |
| Began Marc A | Sale | -13,222 | $30 | $396,660 | 2025-12-12 |
| TYNDALL JOSEPH A. | Sale | -25,108 | $30.98 | $777,771 | 2025-12-10 |
| TYNDALL JOSEPH A. | Derivatives Exercise | 25,108 | 2025-12-10 | ||
| DeVinney Erick Wayne | Sale | -19,517 | $31.21 | $609,087 | 2025-12-10 |
| DALE MICHAEL D | Sale | -61,463 | $31.21 | $1,918,137 | 2025-12-10 |
| Began Marc A | Sale | -9,278 | $31.21 | $289,548 | 2025-12-10 |
| Kemp Jens | Sale | -8,156 | $31.21 | $254,532 | 2025-12-10 |
| THOMAS PAUL | Sale | -21,399 | $29.61 | $633,710 | 2025-12-10 |
| JOHNSON JOHN | Derivatives Exercise | 20,436 | 2025-12-10 | ||
| JOHNSON JOHN | Sale | -45,379 | $31.26 | $1,418,548 | 2025-12-10 |
| Hartley Lindsey Marie | Sale | -14,387 | $31.56 | $453,996 | 2025-12-10 |
| Hartley Lindsey Marie | Derivatives Exercise | 25,000 | 2025-12-10 |
The information provided in this report about AXGN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AxoGen, Inc(NASDAQ:AXGN) 
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without th...
Website: http://www.axogeninc.com
Founded: 2002
Full Time Employees: 371
Sector: Healthcare
Industry: Medical Devices